Incyte to Report Third Quarter Financial Results

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursday, November 5, 2020.

The schedule for the press release and conference call/webcast is as follows:

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13711777.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 90 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005003/en/

Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
[email protected]

Investors
Michael Booth, DPhil
+1 302 498 5914
[email protected]

Source: Incyte

You May Also Be Interested In

• Apogee Enterprises Announces Date for Fiscal 2027 First Quarter Results
• Bimergen Energy (BESS) to Present Path to $400 Million Revenues in The Small Cap Showcase & Water Tower Research Insights, June 9, 2026
• Ferrellgas Partners, L.P. Reports Third Quarter Fiscal Year 2026 Results